Thyrotoxicosis secondary to gestational trophoblastic disease is a rare but clinically relevant complication, the pathophysiology of which is explained by the cross-activation of the TSH receptor induced by excessively high levels of hCG. Here, TSHR is linked to gestational trophoblastic neoplasm.